| [1] |
Wu Xiaomin, Fang Yipeng, Zhang Zhen, Zhang Ye, Jin Cheng.
Clinical application of GEMOX combined with target-immunity therapy in patients with advanced biliary tract cancer
[J]. Clinical Focus, 2024, 39(5): 408-412.
|
| [2] |
ZHANG Wen-hua;TANG Rui-feng;BAI Jian-guo;SUN Chao;SHANG Jun-feng;YU Guo-dong;YAO Hong-liang.
Expression of proliferating cell nuclear antigen and Ki-67 in intrahepatic cholangiocarcinoma and hepatolithiasis tissue
[J]. Clinical Focus, 2014, 29(1): 35-0.
|
| [3] |
BIAN Wei;LIU San-guang;ZHANG Gui-dong;SHI Yun-ming.
Expression of survivin, vascular endothelial growth factor C, proliferating cell nuclear antigen in cholangioncarcinoma and relationship with invasion and metastasis
[J]. CLINICAL FOCUS, 2011, 26(9): 755-0.
|
| [4] |
LIU Su-li;WANG Li-na;FAN Jian-ping;WANG Ding-xin;XING Guo-zhang;ZHANG Jian-sheng.
Analysis of medical imaging characteristics by endoscopic retrograde cholangiopancreatography for patients with cholangiocarcinoma
[J]. CLINICAL FOCUS, 2009, 24(24): 2138-0.
|
| [5] |
.
[J]. CLINICAL FOCUS, 2009, 24(1): 54-55.
|
